Men's Sexual Health
The telehealth testosterone industry, who sells it, what it costs, and how far the standards vary
157 entries. 68 rest on strong human evidence. Ordered with the best evidenced first.
The Clear, Floyd Landis, and How Named Scandals Shaped Anti-Doping
A used syringe mailed to a lab cracked open BALCO and exposed an undetectable designer steroid called 'the clear.'
How to Read a Privacy Policy and Spot When a 'Free Consult' Is a Data Funnel
If the product is free, your sensitive health data is often the product.
The Rules Governing Paid TRT and Supplement Promotion
The disclosure rules most testosterone influencers are quietly breaking.
Semaglutide (Ozempic/Wegovy), Tirzepatide (Mounjaro/Zepbound)
The metabolic drug class that reshaped men's-health telehealth.
The TRT Polycythemia Monitor and the >54% Threshold
The cheapest, most important safety test on TRT - and the most skipped.
How Sensitive ED/TRT/Mental-Health Data Is Collected and Shared
Your erectile-dysfunction intake form is also a marketing asset.
The Controlled-Substance Telehealth Cliff and the Special-Registration Saga
Online TRT runs on a temporary COVID waiver that DEA keeps extending, the permanent rule still is not settled.
How Congress Scheduled Testosterone Over the AMA's Objection, and Then Chased Andro
Congress scheduled testosterone in 1990 even after its own scientific witnesses and the AMA said it did not fit the criteria.
How Labs Tell Your Own Testosterone From a Pharmaceutical Vial
Plant-derived pharmaceutical testosterone carries a lighter carbon-13 fingerprint than the testosterone your body builds, and the lab can read it.
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The 2008 law that says you generally cannot get controlled meds online without ever seeing a doctor in person.
What the 1990 Anabolic Steroids Control Act Means Legally
The same molecule a doctor prescribes is, by federal law, in the same legal tier as ketamine.
1990, 2004, and the Designer Anabolic Steroid Control Act of 2014
Three laws across 24 years, each chasing chemists who kept one molecule ahead.
T/E Ratio, the Steroidal Module, and Carbon-Isotope (IRMS) Confirmation
How testers catch the molecule your body also makes, by tracking ratios over time and reading carbon isotopes.
Individualized Baselines, Bayesian Flagging, and Catching the Microdoser
Instead of one threshold, the passport learns your normal, so a shift that is invisible against the population stands out against yourself.
Controlled-Substance Remote Prescribing & the Recurring Expiration
The entire cash-pay TRT model rests on a flexibility that keeps almost expiring.
How Athletes Navigate Testosterone Under Anti-Doping Rules
For an elite athlete, testosterone is banned at all times, a TUE is the only legal door, and it rarely opens.
SURMOUNT-5 Head-to-Head, Oral Agents, and Retatrutide
The arms race that keeps raising the weight-loss ceiling.
The Screening Number - Assay Methods, the 264/300 ng/dL Cutoffs, and Two-Sample Confirmation
The single number the whole TRT funnel is built on - and the one most abused by timing and method.
Why a Genuinely Deficient Athlete Still Usually Cannot Use Testosterone in Sport
Even an athlete with documented testicular failure faces a TUE bar that testosterone almost cannot clear.
The Meta and Google Pixel Scandals on Telehealth and Hospital Sites
A one-line snippet of JavaScript can leak what you clicked on a clinic's site.
DEA Registration, the Six-Month/Five-Refill Cap, and the Telehealth Consequence
A testosterone script expires in six months and dies after five refills, and that single rule reshapes the whole telehealth model.
Free Plus Albumin-Bound - Definition and When It Is Actually Used
The middle ground between total and free - useful, and easy to over-order.
How Cash-Pay TRT Gets Its Testosterone
Compounded testosterone is not an FDA-approved product, and that distinction matters.
Hair-Loss Management Trade-Offs (Finasteride, Dutasteride)
TRT can speed up balding; the fix has its own side-effect ledger.
At-Home and No-Doctor Testosterone and Hormone Panels
The front door to the funnel: cheap hormone panels that lead to a prescription.
Why a Single Random At-Home Sample Misleads
Testosterone is a moving target the kit photographs at the wrong moment.
The Dietary Supplement Health and Education Act of 1994
The law that lets a 'testosterone booster' reach shelves without a single approval.
Regression to the Mean and the Two-Morning-Sample Rule
One low number is noise; the guideline answer is a second morning draw.
Direct-to-Consumer Drug Advertising History and the US/NZ Exceptionalism
Two countries on Earth let drug ads name the drug. One of them is yours.
Dose-Dependent Hematocrit Rise, the 54% Threshold, and Thrombosis Risk
The single most common dose-limiting side effect of testosterone, and the most-argued-about number on a TRT lab panel.
The Sensitive (LC-MS/MS) vs Standard Immunoassay Problem
The number most likely to be measured wrong and then 'treated' with a drug men rarely need.
The Hidden-Drug Supplement Problem
Most 'natural' enhancement pills FDA tested were spiked with the very drugs they avoid naming.
Equilibrium Dialysis (Gold Standard) vs Calculated (Vermeulen) vs the Discredited Direct Analog Immunoassay
The fraction that actually reaches tissue - measured well three ways and badly a fourth.
Equilibrium Dialysis vs Vermeulen Calculation vs Direct Analog Immunoassay
The reason two clinics can call the same man 'low free T' and 'normal.'
Pricing, Insurance, Cash-Pay, Equity, and Male-Specific Reproductive Notes
A class whose biggest barrier is the price, not the pharmacology.
The Polycythemia Workaround and Blood-Donation Limits
When TRT thickens your blood, the fix is sometimes a needle that takes a pint out.
Public Telehealth Platform (Enclomiphene + PDE5; SPAC 2021)
A public company built on PDE5 inhibitors, with enclomiphene as its testosterone play.
What HIMS Filings Reveal About Revenue Mix, Compounding Strategy, and 2024-2025 Regulatory Friction
A SPAC-era DTC brand whose growth bet collided with the FDA.
Ēnel synthesis monograph: the prescriber-also-seller conflict and the red flags
One rule above all: separate who diagnoses you from who profits when you buy.
Why Cheap Testosterone Panels Are Unreliable at Low Ranges
The same blood, two methods, two different 'verdicts' on your testosterone.
Why TRT Increasingly Bypasses Insurance
The two roads to testosterone, and why the market chose the cash one.
What Is and Isn't Covered, and Why
Insurance will pay for testosterone, if you can prove deficiency the way payers define it.
Where Testosterone and Anabolic Steroids Are OTC, Prescription, or Illegal
The same vial is a felony in one country, a pharmacy purchase in another.
US Direct-to-Consumer Model vs UK NHS, EU, Australian PBS, and Hormone Medical Tourism
The same diagnosis that gets a US man a same-day prescription can take a year of NHS endocrinology referral abroad.
The Gonadotropins - Distinguishing Primary from Secondary Hypogonadism
The two numbers that tell you whether the problem is the testes or the brain.
Private Equity Consolidation of Urology and Men's-Health Clinics
Friendly-PC, MSO management fees, and ancillary-revenue arbitrage.
Why almost everything 'works' at first
Two forces make every testosterone product seem to work: belief and bad timing.
The Macroprolactin and Hook-Effect Pitfalls, and When to Order It
Order it for the right reason, and know the two ways the assay lies.
Screening Controversy, TRT Monitoring Role, and the Free/Total Ratio
A contested screening test with a specific, defensible job in TRT monitoring.
Beyond total testosterone, the numbers that change the picture
Total testosterone alone can mislead, the full panel tells the real story.
Timing, Fasting, the Harmonized-Range Problem (Travison 2017), and How the Industry Cherry-Picks Cutoffs
Every number on the sheet is real; the story sold around them usually is not.
CDC HoSt, Travison 2017 Harmonized Ranges, and Cherry-Picked Cutoffs
Move the line, make a patient: how clinics pick the cutoff that sells.
Broad Telehealth Platform (Generic Sildenafil/Tadalafil)
Roman rebranded as Ro; ED medication is the core revenue engine.
STI/HIV-Status Sensitivity, Location Data, and What Dating Apps Share
HIV status and precise location are among the most dangerous data to leak.
The Confounder - What Raises and Lowers It, and Why It Distorts Total Testosterone
The liver protein that decides how much of your total testosterone you can actually use.
The Practical Shift in Injection Route and Its Evidence
A shorter needle, a shallower stick, and comparable testosterone.
How Hims, Hers, and Ro Built Subscription Men's-Health Businesses
Generic sildenafil as the wedge; subscriptions as the business.
Dialing In the Dose: Trough Targets and the Endocrine Society Range
The goal is the middle of the range, not the top of it.
Testosterone Cypionate Economics ($1.55/mg vs $0.027/mg ASP)
The same molecule, sold for roughly 50 times its Medicare price.
503A vs 503B, the Drug Quality and Security Act, and the FDA Tension
The legal seam where most cheap injectable TRT actually comes from.
SHBG, Albumin, LH/FSH, Estradiol (Sensitive vs Standard E2)
The companion labs that make a borderline result look like a syndrome.
Why the lab value and how you feel often disagree
Symptoms of 'low T' overlap with depression, poor sleep, and stress, so the number can mislead either way.
The Diagnostics Angle on Endocrine Society and AUA Guidance
Should the lab number gate therapy, or should a trial decide? Guidelines say number first.
The 2013-2015 Controversy, the FDA Label, and the TRAVERSE Resolution
A decade-long scare built on two flawed studies, ended by a 5,200-man randomized trial, with two new asterisks.
From Huggins-Era Fear to the Saturation Model and TRAVERSE
For 80 years doctors feared testosterone fed prostate cancer; the saturation model and modern data largely upended that fear.
Cash-Pay vs Insurance, Medication, Membership, and Labs
The drug is cheap; the membership and the labs are where the money goes.
What Endocrine Society 2018 and AUA 2018 Actually Require
The boring schedule that separates real TRT care from a recurring-revenue refill.
Baseline, 6-12 Weeks, Then Periodic, What Good Monitoring Looks Like
The labs are not optional; they are the therapy's safety system.
Algorithmic Prescribing, Automated Consultations, and the Regulatory Questions
When the 'consultation' is a form that almost always says yes.
The Promise, the Accuracy and Liability Concerns, and the Privacy of Conversational Data
A chatbot that feels private is still a data-collection surface.
Smartphone and Consumer Sperm Testing vs Laboratory Andrology
A screen, not a semen analysis: what the app can and cannot see.
Finger-Prick, Saliva, and Mail-In Hormone Panels (Hone, LetsGetChecked, Everlywell, Marek partner labs)
The front door to the funnel: a cheap kit that ends in a prescription.
Pellet-Therapy Training and Licensing Franchise
Markets itself as the largest pellet-therapy training company, revenue from certifying physicians and supplying pellets.
Defy Medical, Tampa-based telemedicine hormone clinic
One of the original online hormone clinics, physician-led rather than influencer-led.
The Hybrid Tampa Clinic and Telehealth Pioneer
One of the original telehealth TRT clinics, with a physical address.
What They Add - and the 'Adrenal Fatigue' Misuse
Real adrenal tests, weaponized to sell a diagnosis endocrinology says does not exist.
The SERM Approach, Monotherapy vs Adjunct
Raise your own testosterone instead of replacing it.
Fertility-Preserving SERM, Used Off-Label for Hypogonadism
The telehealth answer to 'TRT without losing fertility.'
The Anastrozole Controversy and Why Guidelines Discourage Chasing a Low E2
The most consequential everyday argument in TRT practice: should you suppress estrogen at all?
hCG, Low-Dose hMG/FSH, and Enclomiphene as a Sparing Alternative
Standard TRT can render a man infertile within months, and many starting it are never told.
Endocrinologist vs urologist vs 'men's clinic'
The single most consequential choice is who evaluates you, not which drug.
Topical-Cream, Low-Friction Subscription TRT
'Set it and forget it' topical testosterone, marketed on convenience.
Weight Loss, Aromatization, and Obesity-Related Hypogonadism
Fat loss can lift testosterone, but GLP-1 is not a T drug.
Muscle Preservation, Resistance Training, and GLP-1-plus-Testosterone
Rapid weight loss costs muscle; clinics market the TRT add-on as the fix.
GnRH Analog, The Compounded Fertility Adjunct in TRT
The clinic-friendly hCG stand-in for preserving testicular function on TRT.
Testicular Volume and Fertility Preservation, Dosing, Supply, and the Compounding Cliff
The shot that keeps the testicles online while testosterone shuts them down.
Why High-SHBG and Low-SHBG Men Need Different Protocols
The same milligram dose lands very differently on a high-SHBG man than a low-SHBG one, which is why one-size protocols misfire.
Subscription TRT With Bundled Labs ($129/month)
States lab work is included in the monthly fee.
Hims & Hers Health, Inc. (NYSE: HIMS)
The category-defining men's-health storefront, and the loudest cautionary tale in compounding.
Hone Health, at-home-testing-to-TRT telehealth
The company that both runs the test and sells the treatment the test justifies.
Membership Telehealth TRT Platform (CEO Saad Alam)
Tiered membership; the company says it tests every 90 days.
Marketing Claims vs. Evidence for DTC TRT and Enclomiphene Players
Internal white papers and 4x claims; an FDA-rejected molecule.
Weekly IM vs Twice-Weekly vs Every-Other-Day vs Daily SubQ
The same weekly dose feels completely different split four ways.
Weekly IM vs Twice-Weekly vs Daily SubQ, the Peak-Trough and Hematocrit Rationale
How often you inject is the most-debated practical knob on injectable TRT, and the evidence is thinner than the certainty online.
LifeMD, Inc. (Nasdaq: LFMD) and its RexMD men's-health brand
The other public DTC player, where men's sexual health funds a pivot to weight loss.
The Cash-Pay Men's-Clinic Model and the Endocrine Society / Insurer Pushback
Hormone optimization rebranded; cash at the door, evidence at the margins.
The Optimization Coaching Model
Coaching first, prescription second: the optimization template.
Enclomiphene + Pregnenolone 'Natural Optimization' Platform
Markets enclomiphene as 'natural' testosterone optimization, distinct from direct TRT.
Hims & Hers, Ro, and the Compounded-Semaglutide Boom and Bust
How weight loss became the growth engine of men's telehealth.
A pocket checklist for any product or prescription
Five questions that cut through most of the marketing.
How to spot a prescribe-first operation
If they prescribe on one lab and never mention fertility, walk.
Ro / Roman (Ro Health, Inc.), private DTC telehealth
The DTC pioneer that started with the ED pill and pivoted into a weight-loss engine.
GHRH(1-29), The Peptide That Was FDA-Approved, Then Discontinued
The one anti-aging GH-releasing peptide with a real FDA history, for a different use.
The questions to answer before, not after, starting
TRT is usually a lifelong commitment, the decision deserves more than a lab number.
The Quiet Shift in How Testosterone Is Injected
The needle got shorter and shallower, and a generation of TRT patients stopped dreading injection day.
Compounded Creams, Scrotal Absorption, DHT, and Transference
The most absorbent skin on the body is also the riskiest to share.
How Prescribing Incentives Are Structured, The Prescriber-Also-Seller Conflict
If the consult is free, the prescription is the product.
How Testosterone Became a Mass-Market Product, and the Regulatory Backlash
A marketing campaign turned aging into a diagnosis, until the FDA pushed back.
Aromatase-Inhibitor Use in TRT, Contested and Often Over-Prescribed
The estrogen blocker many men take and most may not need.
Pairing Weight-Loss Injectables With Testosterone
The fastest-growing cross-sell in men's telehealth.
What men are often not told before starting
The three things many men only learn after starting: fertility, permanence, and monitoring.
When the Business Model Rewards Prescribing
A subscription only earns while the prescription continues.
Overview of the Online Testosterone Marketplace
How COVID deregulation turned testosterone into a subscription.
A time-limited test with predefined goals
If a 3-6 month trial doesn't clearly help, stopping is the right call.
Compounded Oral-Mucosal Delivery and the Striant Precedent
Testosterone that absorbs through the cheek, skipping the liver.
What a 'Good' Testosterone Level Actually Is, and When to Draw It
Half the arguments about a TRT lab result are really arguments about when the blood was drawn.
Volume-Model, Low-Cost TRT Subscription
One of the lowest-priced platforms, built on volume.
Oura, WHOOP, Eight Sleep and What Sleep/HRV/Recovery Data Can and Cannot Tell You
Your ring tracks your sleep. It does not measure your testosterone.
Where TRT Shades Into PED Use, A Factual, Harm-Reduction Distinction
The line between a replacement dose and a performance dose is the dose.
Hormone-Optimization Telehealth Platform
An 'optimization'-branded entrant in the crowded TRT telehealth field.
Function Health, InsideTracker, Marek - and Biomarker Overreach
100 biomarkers, an 'optimal' color code, and a path to a prescription.
Biote Corp., hormone-pellet franchise and provider network
A franchise model: certify thousands of clinicians, sell the pellets they implant.
Blokes (men) and Joi (women), 'optimization' telehealth brands
The 'optimization and longevity' branding applied to the same TRT-and-peptides menu.
Body Protection Compound-157, The 'Healing Peptide'
The internet's favorite recovery peptide, with a near-empty human evidence file.
BPC-157, The Unapproved 'Healing Peptide'
The internet's favorite recovery peptide, and a regulatory flashpoint.
GHRH Analog, The Drug-Affinity-Complex Half-Life Story
A once-weekly GHRH, clever chemistry, no finished-drug approval.
503A/503B Pathway, Shortage Resolution, and the Crackdown
A regulatory window that opened with shortage and closed with resolution.
How Telehealth Uses Compounding to Sell Non-FDA-Approved Formulations
The legal channel for selling drugs the FDA never approved.
Myostatin Inhibition, Big Muscle Claims, Failed Clinical Programs
The 'double-muscle' dream, with a real clinical cautionary tale attached.
The Original Growth-Hormone-Releasing Peptides, Hunger, Cortisol, Prolactin
The first-generation GHRPs, more hunger and cortisol, more off-target noise.
Combination Use in Men's Optimization and Hormone Clinics
The optimization-clinic upsell that bundles two prescription markets.
Cardiometabolic Pathway, Early Signals, and Conflicting Reports
Plausible upside through metabolic repair; direct proof is thin.
The Compounded hCG-Alternative Trend in TRT
The clinic-friendly stand-in for hCG when hCG got scarce.
Gorilla Mind supplements and the More Plates More Dates media-commerce engine
Where the audience that trusts the hormone content buys the pre-workout and the labs.
The Research-Chemical Bodybuilding IGF-1 Variants
Bodybuilding's direct IGF-1 play, potent, hypoglycemia-prone, unproven.
Where Men Source It Abroad, Legal and Quality Risks
Over-the-counter abroad, but you're trusting a label you can't verify.
The 'Clean' GHRP, Selective GH Release
GH release without the hunger, cortisol, or prolactin, but no marketed product.
TRT Platform, Off-Label Ad Claims Documented
Google ads promising 'explosive drive', most of which are off-label claims.
The 'Health Optimization' Influencer-to-Clinic Funnel (Derek / More Plates More Dates)
When the educator who recommends bloodwork also co-owns the clinic.
Marek Health, influencer-founded hormone optimization platform
The purest influencer-to-clinic funnel: the audience is the top of the sales pipeline.
Maximus Tribe, enclomiphene-led DTC hormone platform
Built on a molecule the FDA declined to approve, sold with in-house data as the headline.
The 'Barbie Drug', Tanning Peptide, PT-141's Ancestor
Bought online to tan; erections were the side effect that launched a real drug.
The Compounding Boom, the FDA Bulks-List Whiplash, and Why Most Aren't Approved
How unapproved peptides ride along with your TRT subscription, and where the law actually stands.
DSHEA, the Andro Era, and the FDA/DEA Crackdowns That Followed
Sold on supplement shelves as 'natural,' many of these products are unlisted steroids one tweak ahead of the law.
Forums, Subreddits, and DIY Protocol Culture
Where men learn protocols, vet clinics, and sometimes route around them.
Unapproved Drugs, the Proposed SARMs Control Act, and FDA/FTC Warning Letters
Labeled 'research chemical, not for human consumption', a disclaimer that is the whole legal trick.
FirmTech and the Connected-Device Market: Data Practices and Efficacy Claims
A ring that logs your erections is logging extremely intimate data.
The Tissue-Repair Peptide, WADA-Prohibited, Human Data Thin
Marketed as a systemic repair peptide; banned in sport, unproven in people.
Quantified-Self, Whole-Body Scans, and the Risk of Treating the Number Instead of the Person
More data points is not the same as more health.
Ipamorelin, CJC-1295, Sermorelin, Tesamorelin, MK-677
The anti-aging clinic's favorite category, big claims, thin evidence for most members.
Physician-Influencers With a Commercial Stake in Prescribing
When the doctor promoting pellets is also the one selling the procedure.
How Peptides Are Sold Alongside TRT, the Regulatory Gray Zone
Where 'recovery peptides' ride along with your testosterone subscription.
Restart Protocols, the Borrowed 'PCT', and the Uncertain Timeline
Getting off TRT is harder and slower than getting on it, and the 'PCT' protocols come from bodybuilding, not clinical trials.
Where SARMs Bleed Into the Peptide Gray Market
Different molecules, same 'not for human consumption' loophole and same risky vendors.
Sub-Therapeutic Dosing, Biohacking, and the Longevity Pitch
A marketing strategy in search of an evidence base.
The 'T-Booster' Category Economics, Proprietary Blends, Amazon, and Commodity-Herb Margins
Commodity herbs, hidden doses, and a structure-function escape hatch.
UGL Testosterone, Raw Powder, and Source Boards
The unregulated channel that cash-pay friction pushes men toward.